Benjamin L. Woolbright

3.6k citations
64 papers · 2.8k indexed · 1 hit paper · h-index 28

Impact in

  • Pharmacology top 0.2%
    • Drug-Induced Hepatotoxicity and Protection
  • Hepatology top 1%
    • Liver Disease and Transplantation
    • Liver physiology and pathology

Papers in

    • Drug-Induced Hepatotoxicity and Protection 23
    • Liver Disease and Transplantation 11

Benjamin L. Woolbright

62 papers receiving 2.7k citations

Hit Papers

Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure 2016 · 316 citations
3162016202620192022100200300

Peers

Benjamin L. Woolbright
Comparison fields: 5 of 115
  • Pharmacology 839
  • Hepatology 728
  • Epidemiology 857
  • Oncology 628
  • Cancer Research 312
Replace Yingqun Zhou with:
Yingqun Zhou China
Francisco Javier Cubero Spain
Tsutomu Matsubara Japan
Kuo Du United States
Sanda Win United States
Songrong Ren United States
Robert S. Britton United States
Bo Kong United States
Marcelo G. Roma Argentina
Hong‐Min Ni United States
Benjamin L. Woolbright relative to Yingqun Zhou China Yingqun Zhou's profile →
Citations per field
00.5×1.5×2.3×
Yingqun Zhou · 1×
Citations per year

Countries citing papers authored by Benjamin L. Woolbright

Since Specialization
Citations

This map shows the geographic impact of Benjamin L. Woolbright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Woolbright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Woolbright more than expected).

Fields of papers citing papers by Benjamin L. Woolbright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Woolbright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Woolbright. The network helps show where Benjamin L. Woolbright may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin L. Woolbright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin L. Woolbright Line = papers co-authored together Benjamin L. Woolbright links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20241
3 20242
4 20246
5 20234
6 202216
7 202111
8 2020121
9 201917
10 201916
11 201883
12 201875
13 20179
14 201649
15 20157
16 201531
17 201527
18 201477
19 20142
20 200821

About Benjamin L. Woolbright

Benjamin L. Woolbright is a scholar working on Pharmacology, Hepatology, Biochemistry, Cancer Research and Epidemiology, having authored 64 papers that have together received 2.8k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (23 papers), Liver Disease Diagnosis and Treatment (15 papers), Drug Transport and Resistance Mechanisms (14 papers), Liver Disease and Transplantation (11 papers), Bladder and Urothelial Cancer Treatments (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Epigenetics and DNA Methylation (8 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). The work is most often cited by research in Pharmacology (839 citations), Hepatology (728 citations), Epidemiology (857 citations), Oncology (628 citations) and Cancer Research (312 citations). Benjamin L. Woolbright has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Hartmut Jaeschke, John A. Taylor, Mitchell R. McGill, Wen-Xing Ding, Bryan L. Copple, Ganeshkumar Rajendran, Robert A. Harris, Anup Ramachandran, James P. Luyendyk and Jessica A. Williams. Their work appears in journals such as Nature Reviews Urology, Toxicological Sciences, Food and Chemical Toxicology, Urologic Oncology Seminars and Original Investigations and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026